About this trial
To explore surgical strategies that reduce perioperative neurologic complications in cardiovascular surgery, with the aim of improving perioperative outcomes and quality of life while reducing the socioeconomic burden. Specifically:
This multicenter, randomized controlled clinical trial will evaluate the benefits of a novel aortic no-touch technique in reducing perioperative silent brain infarction(SBI) among patients undergoing surgical treatment for coronary artery disease. The findings are expected to provide a safe and effective myocardial revascularization strategy for individuals at high risk of cerebral ischemia.
Eligibility criteria
Qualifiers
Adult patients (>18 years old) with multivessel coronary artery disease who are scheduled to undergo isolated off-pump coronary artery bypass grafting and who provide informed consent to participate in this study.
Disqualifiers
Indications for cardiopulmonary bypass surgery (or no contraindications to on-pump surgery);
Great saphenous vein is unsuitable for use as a graft conduit;
Subclavian artery stenosis or occlusion, or any contraindication to the use of the internal mammary artery as a graft conduit;
History of previous cardiac surgery;
Trial design
Treatments tested in this trial
- Aortic no-touch coronary artery bypass grafting (RIMA-SVG)
- Conventional off-pump CABG with partial clamping of the ascending aorta (Ao-SVG)